Farmakoterapia w Psychiatrii i Neurologii

Pełna treść

2/2024 vol. 40
Artykuł przeglądowy

Postępy w badaniach nad farmakoterapią tzw. nałogów behawioralnych

Bogusław Habrat 1
  1. Polish Society for Research on Addiction; Polskie Towarzystwo Badań nad Uzależnieniami
Farmakoterapia w Psychiatrii i Neurologii 2024, 40 (2), 95–105
DOI: https://doi.org/10.5114/fpn.2024.147142
Data publikacji online: 2025/03/31
Plik artykułu
2C0_IPiN_FARM_2024-2D.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Almalki MH, Alsuraikh MA, Almalki E, Aziz F, Almazrouei R, AlDahmani KM, et al. Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study. Pituitary. 2024; 27 (2): 197-203.
  2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-5. APA, Washington D.C. 2013.
  3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-5 TR. APA, Washington D.C. 2022.
  4. Antons S, Engel J, Briken P, Krüger THC, Brand M, Stark R. Treatments and interventions for Compulsive Sexual Behavior Disorder with a focus on Problematic Pornography Use: A preregistered systematic review. J Behav Addict. 2022; 11 (3): 643-666.
  5. Bartley CA, Bloch MH. Meta-analysis: pharmacological treatment of pathological gambling. Expert Rev Neurother. 2013; 13 (8): 887-894.
  6. Black DW, Gabel J, Hansen J, Schlosser S. A double-blind comparison of fluvoxamine versus placebo in the treatment of Compulsive Buying Disorder. Ann Clin Psychiatry, 2000; 12 (4): 205-211.
  7. Borgogna NC, Owen T, Johnson D, Kraus SW. No magic pill: A systematic review of the pharmacological treatments for Compulsive Sexual Behavior Disorder. J Sex Res. 2024. 61 (9): 1328-1341.
  8. Brand M, Rumpf H-J, Demetrovics Z, Müller A, Stark R, King DL, et al. Which conditions should be considered as disorders in the International Classification of Diseases (ICD-11) designation of „other specified disorders due to addictive behaviors”? J Behav. Addict. 2020, 11 (2): 150-159.
  9. Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC, et al. Management of impulse control and related disorders in Parkinson’s disease: An expert consensus. Mov Disord. 2024; 39 (2): 235-248.
  10. Di Nicola M, De Crescenzo F, D’Alò GL, Remondi C, Panaccione I, Moccia L, et al. Pharmacological and psychosocial treatment of adults with gambling disorder: a meta-review. J. Addict. Med. 2020; 14 (4): e15-e23.
  11. Dong GH, Dai J, Potenza MN. Ten years of research on the treatments of internet gaming disorder: A scoping review and directions for future research. J Behav Addict. 2024; 13 (1): 51-65.
  12. Farkouh R, Audette-Chapdelaine S, Brodeur M. Pharmacotherapy and gambling disorder: a narrative review. J Addict Dis. 2024; 42 (4): 274-288.
  13. Fusaroli M, Raschi E, Giunchi V, Menchetti M, Rimondini Giorgini R, De Ponti F, et al. Impulse control disorders by dopamine partial agonists: A pharmacovigilance-pharmacodynamic assessment through the FDA Adverse Event Reporting System. Int J Neuropsychopharmacol. 2022; 25 (9): 727-736.
  14. Goslar M, Leibetseder M, Muench HM, Hofmann SG, Laireiter AR. Pharmacological treatments for disordered gambling: A meta-analysis. J Gambl Stud. 2019; 35 (2): 415-445.
  15. Grant JE, Driessens C, Chamberlain SR. Silymarin (milk thistle) treatment of adults with gambling disorder: A double-blind, placebo-controlled trial. Clin Neuropharmacol. 2024; 47 (2): 54-58.
  16. Grant JE. Three cases of compulsive buying treated with naltrexone. Int J Psychiatry Clin Pract. 2003; 7 (3): 223-225.
  17. Griffiths MD: A ‘components’ model of addiction within a biopsychosocial framework. J Subst Use. 2005; 10: 191-197.
  18. Griffiths MD: Compulsive sexual behaviour as a behavioural addiction: the impact of the internet and other issues. Addiction. 2016; 111 (12): 2107-2108.
  19. Habrat B. (red.). Zaburzenia uprawiania hazardu i tzw. nałogów behawioralnych. Instytut Psychiatrii i Neurologii, Warszawa 2016.
  20. https://icd.who.int/en
  21. Hamblin R, Karavitaki N. Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: A systematic review. Arch Med Res. 2023; 54 (8): 102910.
  22. Kraus SW, Etuk R, Potenza MN. Current pharmacotherapy for gambling disorder: a systematic review. Expert Opin Pharmacother. 2020, 21 (3): 287-296.
  23. Kraus SW, Voon V, Potenza MN. Should compulsive sexual behavior be considered an addiction? Addiction. 2016; 111 (12): 2097-2106.
  24. Kuss DJ, Griffiths MD, Pontes HM. Chaos and confusion in DSM-5 diagnosis of Internet Gaming Disorder: Issues, concerns, and recommendations for clarity in the field. J Behav Addict. 2017; 6 (2): 103-109.
  25. Lew-Starowicz M, Draps M, Kowalewska E, Obarska K, Kraus SW, Gola M. Tolerability and efficacy of paroxetine and naltrexone for treatment of compulsive sexual behaviour disorder. World Psychiatry. 2022; 21 (3): 468-469.
  26. Mestre-Bach G, Potenza MN. a) Pharmacological management of gambling disorder: an update of the literature. Exp Rev Neurother. 2024; 24 (4): 391-407.
  27. Mestre-Bach G, Potenza MN. b) Current understanding of Compulsive Sexual Behavior Disorder and co-occurring conditions: What clinicians should know about pharmacological options. CNS Drugs. 2024; 38 (4): 255-265.
  28. Murphy L, Ly T, DiMario K, Mihowich T, Fedoroff JP. Treatment of pramipexole-induced problematic sexual behaviors. Prim Care Companion CNS Disord. 2021; 2 3(1): 20br02663.
  29. Müller A, Laskowski NM, Thomas TA, Antons S, Tahmassebi N, Steins-Loeber S, et al. Update on treatment studies for compulsive buying-shopping disorder: A systematic review. J Behav Addict. 2023; 12 (3): 631-651.
  30. Nicoli de Mattos C, Kim HS, Marasaldi RF, Requião MG, de Oliveira EC, Zambrano Filomensky T, et al. 12-week randomized, double-blind, placebo-controlled clinical trial of topiramate for the treatment of compulsive buying disorder. J Clin Psychopharmacol. 2020; 40 (2): 186-190.
  31. Pettorruso M, Di Carlo F, Romeo VM, Jimenez-Murcia S, Grant JE, Martinotti G, et al. The pharmacological management of gambling disorder: if, when, and how. Expert Opin Pharmacother. 2023, 24 (4): 419-423.
  32. Roza TH, Noronha LT, Shintani AO, Massuda R, Lobato MIR, Kessler FHP, et al. Treatment approaches for problematic pornography use: A systematic review. Arch Sex Behav. 2024; 53 (2): 645-672.
  33. Sá RRC, Coelho S, Parmar PK, Johnstone S, Kim HS, Tavares H. A systematic review of pharmacological treatments for Internet Gaming Disorder. Psychiatry Investig. 2023; 20 (8): 696-706.
  34. Schünemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014; 186 (3): E123-142.
  35. Sharma R, Weinstein AM. Recent treatment and novel imaging studies evaluating treatment of Internet Gaming Disorder: a narrative review. Front Psychiatry. 2024; 15: 1408560.
  36. Soileau LG, Talbot NC, Storey NR, Spillers NJ, D’antoni JV, Carr PC, et al. Impulse control disorders in Parkinson’s disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis. Neurol Sci. 2024; 45 (4): 1399-1408.
  37. Williams BD, Lee K, Ewah SO, Neelam K. Aripiprazole and other third-generation antipsychotics as a risk factor for impulse control disorders: A systematic review and meta-analysis. J Clin Psychopharmacol. 2024; 44 (1): 39-48.
ZGŁASZANIE PRAC
Udostępnij
without publication fees
without publication fees
Zintergrowane z
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications